INTEGRA supports groundbreaking brain tumor research

INTEGRA Biosciences is proud to be supporting vital translational research into diffuse intrinsic ponsglioma (DIPG) – a rare childhood brain tumor – at the Ludwig Maximilian University of Munich (LMU) with a festive donation of 20,000 EUR. Brain tumors in children are thankfully rare, but are often associated with poor prognoses and low survival rates.

Dr Alexander Beck’s DIPG Fighter research group at the LMU focuses on finding new therapies for DIPG, which usually affects children between five and nine years of age, with no significant long-term survival beyond five years. The group routinely uses a range of INTEGRA products – including the ASSIST PLUS pipetting robot, VOYAGER adjustable tip spacing pipettes, EVOLVE manual pipettes and PIPETBOY acu 2 pipette controllers – and INTEGRA is delighted to be supporting this valuable work with this year’s festive donation, helping the rapid translation of research findings to the clinic.

Alexander commented: “We are delighted to have been chosen as the recipient of this generous donation. We are dedicated to the rapid translation of drugs for pediatric brain tumors, with a particular emphasis on preclinical drug screening and testing. This donation will fund the continuation of our existing cutting-edge research projects, with the ultimate goal of identifying approved therapeutics that can be repurposed for new clinical applications.”

"We love encouraging initiatives that make the world a better place and, this year, we’ve been able to pledge 20,000 Euros to help advance the groundbreaking brain tumor research conducted at the LMU. We are excited to see how this festive contribution will be used to help children around the world with this disease.”

Dr Lukas Keller, Marketing Communications Director at INTEGRA

Visit the INTEGRA website to learn more.

About INTEGRA Biosciences

INTEGRA Biosciences (https://www.integra-biosciences.com) is a leading provider of high-quality laboratory tools and consumables for liquid handling and media preparation. The company is committed to creating innovative solutions which fulfil the needs of its customers in research, diagnostics and quality control within the life sciences markets and medical sector.

Today, INTEGRA innovative laboratory products are widely used all around the world. More than 100 distribution partners form a worldwide sales network providing responsive and competent services to customers. These distribution partners are supported by a highly motivated and experienced team of specialists at the company headquarters in Zizers, Switzerland and Hudson, NH, USA. INTEGRA is an ISO 9001 certified company.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    INTEGRA Biosciences. (2021, December 21). INTEGRA supports groundbreaking brain tumor research. AZoLifeSciences. Retrieved on May 22, 2022 from https://www.azolifesciences.com/news/20211221/INTEGRA-supports-groundbreaking-brain-tumor-research.aspx.

  • MLA

    INTEGRA Biosciences. "INTEGRA supports groundbreaking brain tumor research". AZoLifeSciences. 22 May 2022. <https://www.azolifesciences.com/news/20211221/INTEGRA-supports-groundbreaking-brain-tumor-research.aspx>.

  • Chicago

    INTEGRA Biosciences. "INTEGRA supports groundbreaking brain tumor research". AZoLifeSciences. https://www.azolifesciences.com/news/20211221/INTEGRA-supports-groundbreaking-brain-tumor-research.aspx. (accessed May 22, 2022).

  • Harvard

    INTEGRA Biosciences. 2021. INTEGRA supports groundbreaking brain tumor research. AZoLifeSciences, viewed 22 May 2022, https://www.azolifesciences.com/news/20211221/INTEGRA-supports-groundbreaking-brain-tumor-research.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post
You might also like...
Win an EVOLVE Manual Pipette Starter Pack from INTEGRA